Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity
about
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advancesAlanine scanning of a putative receptor binding surface of insulin-like growth factor-IThe metabolic and mitogenic properties of basal insulin analoguesTargeting the insulin-like growth factor pathway in hepatocellular carcinomaRegulation of cardiac autophagy by insulin-like growth factor 1Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEXThe IGF system in thyroid cancer: new concepts.Development of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensorInsulin and insulin like growth factor II endocytosis and signaling via insulin receptor BHuman monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studies.Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.Autocrine/paracrine role of insulin-related growth factors in neurogenesis: local expression and effects on cell proliferation and differentiation in retinaMechanisms by which IGF-I may promote cancerInsulin receptor variant forms and type 2 diabetes mellitus.Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms.The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth.Proinsulin in development: New roles for an ancient prohormone.LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.The double trouble of metabolic diseases: the diabetes-cancer link.In vitro silencing of the insulin receptor attenuates cellular accumulation of fibronectin in renal mesangial cells.Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts.Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathwayNovel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.Insulin signaling pathways and cardiac growth.Differences in metabolic and mitogenic signallingof insulin glargine and AspB10 human insulin in rats [corrected].Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathwayThe IGF axis and placental function. a mini review.A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factorsIGF ligand and receptor regulation of mammary developmentInsulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells.Role of IGF-1 in glucose regulation and cardiovascular disease.Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes MellitusInsulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects.Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.Type 2 diabetes and cancer: what is the connection?Insulin-like growth factor receptor type I as a target for cancer therapy.The IGF system.
P2860
10a7d066592bedd26d3668ae7fd3b21e2a91af9f1db778df498ac6704111cefb2c8a1b4c13eeae0c587744668f6960825d9e274db96d79410e0413796bc349ccfff7a2a1f8ef3bc62fa7e883d4b367e07bde2cc9a710cc56b306cb85d4d7a91b44f95cf3c879a6a63df338d53baa468c50aa6c638d8780fcddb4f5354e818e9989b780bda4a145681e3f070fec659d68a4d911cae1f6e5b109e4d7a41f6ddc34f773c76fd736b0ff101649fbb6c69cfeff68fde7
P248
Q21131281-058DACB1-A71A-4053-A2A4-ECF624820C57Q24608585-2C83D48F-D980-4C71-B53A-15E1AF1C320BQ26991486-C0E240C9-0B1F-4060-A5DB-41BDFC0E0CDBQ27006846-FE028C14-F398-4A2A-8268-2D573C9A905FQ27025162-EC34FE61-07E4-48BF-9881-62D1C1FE8553Q28273812-191578B2-759E-450E-B185-ED0B1363A1AEQ28365951-5DBC9A2F-53B6-46C3-855F-069EEFF020D6Q28541161-26710BAD-D258-4E69-9151-DC9D129B477EQ30538044-B8FD38F9-771F-4839-90D9-6430ED876E8DQ33614794-372D1461-7397-43F8-9748-0B0645FC45D2Q33857313-A75E8304-332D-4C7C-8852-C79AA35540A4Q33873341-7D5B3A8D-ECB6-43CC-A670-9B46E773821FQ34180961-1A63343E-167F-4F5B-8A28-BC425017E92CQ34189889-C8E32B41-DE3E-437B-9C6A-235B82E33B6DQ34465092-1D3378D2-D483-4389-BB5B-838D1C8CE4DBQ34494973-F1235D48-D50C-4F8A-A28E-0BB9DC8FC96EQ34510776-2B931894-6A74-4412-B159-A218031BD69EQ35221829-30EB7E74-7DAA-495C-8C5F-2F9F67CFE441Q36058422-E57087A7-D3FE-4D26-9D6C-F65314DDF8E0Q36427446-54873ACF-1EE5-4E0F-9FFA-DD05F14BB96AQ36440699-57B11094-E895-423F-98DF-B64C9A67EAF0Q36489859-25184F71-0BBA-4CD7-BDEA-5B496C5CDCC0Q36565904-EFB9DF25-3B88-4B27-AE83-BCE10F7E1AA9Q36742620-820BD494-D578-432B-8AD7-41519E287928Q36976992-4BBA31E0-6D45-44E1-8145-4B242B22D49DQ36984213-4B26F668-1F98-43B5-9F99-C3662E8CEFC6Q37047940-7DEB77DA-C073-484C-AB63-B1C952274EA4Q37064809-7443D228-4DFD-4634-AD18-18B38528DA87Q37105231-384C31A7-262F-4A78-A366-BC37B9B4EBECQ37149891-FA39C159-9F3B-4594-AB19-24CA4E2A3825Q37268071-0480D711-4F22-4AD1-B7BB-1B377A461B18Q37269401-57E077DB-D020-4AB6-8C37-E49A7FB714B2Q37277475-1A6EB407-FECD-4F58-AE30-797825BB244DQ37281132-7A94F598-E188-4F6D-BA0B-ED58AEB4E9C1Q37362223-B6CBA596-B719-4386-933A-A2EEF0F981EEQ37367772-DB9594DA-A27C-400C-A7C1-A5A9DD23B0C2Q37503147-A397C99E-A109-498F-8485-B3FD19545E86Q37716718-17B8688F-396C-4133-9004-0039B2FDB2C4Q37773265-C7601694-4DB5-4CEE-9A93-4F8FD818699EQ37806130-658F32E6-8DEA-4FFF-BD2C-E54186D46E09
P2860
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity
description
1993 nî lūn-bûn
@nan
1993 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մարտին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@ast
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en-gb
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@nl
type
label
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@ast
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en-gb
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@nl
prefLabel
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@ast
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en-gb
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@nl
P2093
P2860
P921
P356
P1433
P1476
Purified hybrid insulin/insuli ...... ot insulin, with high affinity
@en
P2093
P2860
P304
P356
10.1042/BJ2900419
P407
P478
290 ( Pt 2)
P577
1993-03-01T00:00:00Z